Early-stage multi-cancer detection through a plasma extracellular vesicle protein signature
Journal Title
Cell Reports Medicine
Publication Type
Online publication before print
Abstract
Small extracellular vesicles (sEVs) offer a promising, non-invasive method for cancer detection. Despite global research efforts, successful translation of sEV-based diagnostics remains limited. In this study, we identify a 4-protein sEV biomarker panel (thrombospondin-1, nidogen-1, pentraxin-3, and versican) based on proteomic profiles obtained from an isogenic cancer cell line model. The panel's performance is validated across 22 cancer cell lines and 764 retrospective plasma/serum samples spanning multiple cancer types, yielding robust performance (area under the curve [AUC]: 0.91-1.00). To facilitate clinical application, we develop a multiplex sEV device that integrates nanoshearing-based microfluidics and surface-enhanced Raman scattering (SERS) for simultaneous detection of the 4-protein panel. Using this device on a prospective cohort of 68 patients, we accurately differentiate between benign lung changes and early-stage lung cancer. These findings underscore the potential of sEVs as diagnostic markers for cancer screening. Furthermore, the multiplex microfluidic device's scalability, simplicity, and cost-effectiveness indicate feasibility for large-scale population screening.
Keywords
extracellular vesicles; liquid biopsy; lung cancer screening; microfluidics; miniaturized biosensor; multi-cancer early diagnosis; surface-enhanced Raman spectroscopy
Department(s)
Radiation Oncology
Open Access at Publisher's Site
https://doi.org/10.1016/j.xcrm.2026.102694
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2026-04-07 12:09:46
Last Modified: 2026-04-14 03:18:19
An error has occurred. This application may no longer respond until reloaded. Reload 🗙